Anti-YTHDF2 Recombinant Monoclonal

Item number Size Datasheet Manual SDS Delivery time Quantity Price
A700-297-T 20 µl (2 blots) -

2 - 8 business days*

172.00€
A700-297 100 µl (10 blots) -

2 - 8 business days*

655.00€
 
Protein function: Specifically recognizes and binds N6-methyladenosine (m6A)- containing RNAs,... more
Product information "Anti-YTHDF2 Recombinant Monoclonal"
Protein function: Specifically recognizes and binds N6-methyladenosine (m6A)- containing RNAs, and regulates mRNA stability (PubMed:24284625, PubMed:26046440, PubMed:26318451). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing (PubMed:24284625, PubMed:22575960, PubMed:25412658, PubMed:25412661). Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT and ribonuclease P/MRP complexes, depending on the context (PubMed:24284625, PubMed:26046440, PubMed:27558897, PubMed:30930054). M6A-containing mRNAs containing a binding site for RIDA/HRSP12 (5'-GGUUC-3') are preferentially degraded by endoribonucleolytic cleavage: cooperative binding of RIDA/HRSP12 and YTHDF2 to transcripts leads to recruitment of the ribonuclease P/MRP complex (PubMed:30930054). Other m6A-containing mRNAs undergo deadenylation via direct interaction between YTHDF2 and CNOT1, leading to recruitment of the CCR4-NOT and subsequent deadenylation of m6A- containing mRNAs (PubMed:27558897). Required maternally to regulate oocyte maturation: probably acts by binding to m6A-containing mRNAs, thereby regulating maternal transcript dosage during oocyte maturation, which is essential for the competence of oocytes to sustain early zygotic development. Also involved in hematopoietic stem cells specification by binding to m6A-containing mRNAs, leading to promote their degradation (PubMed:30065315). Also acts as a regulator of neural development by promoting m6A-dependent degradation of neural development-related mRNA targets. Regulates circadian regulation of hepatic lipid metabolism: acts by promoting m6A-dependent degradation of PPARA transcripts (PubMed:30428350). Regulates the innate immune response to infection by inhibiting the type I interferon response: acts by binding to m6A-containing IFNB transcripts and promoting their degradation (PubMed:30559377). Also acts as a promoter of cap-independent mRNA translation following heat shock stress: upon stress, relocalizes to the nucleus and specifically binds mRNAs with some m6A methylation mark at their 5'-UTR, protecting demethylation of mRNAs by FTO, thereby promoting cap-independent mRNA translation (PubMed:26458103). [The UniProt Consortium]
Keywords: Anti-CLL-associated antigen KW-14, Anti-Renal carcinoma antigen NY-REN-2, Anti-High-glucose-regulated protein 8, Anti-YTH domain-containing family protein 2
Supplier: Bethyl Laboratories
Supplier-Nr: A700-297

Properties

Application: WB, FC
Antibody Type: Monoclonal
Clone: BLR297M
Conjugate: No
Host: Rabbit
Species reactivity: human, mouse
Format: Antigen Affinity Purified

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-YTHDF2 Recombinant Monoclonal"
Write a review
or to review a product.
Viewed